Citigroup Inc Xencor Inc Transaction History
Citigroup Inc
- $190 Billion
- Q1 2025
A detailed history of Citigroup Inc transactions in Xencor Inc stock. As of the latest transaction made, Citigroup Inc holds 165,179 shares of XNCR stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
165,179
Previous 117,988
40.0%
Holding current value
$1.25 Million
Previous $2.71 Million
35.19%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding XNCR
# of Institutions
211Shares Held
78.4MCall Options Held
3.4KPut Options Held
1.9K-
Black Rock Inc. New York, NY11.1MShares$84.1 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.76MShares$73.9 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$59.8 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$46.5 Million5.14% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$29.8 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $452M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...